235 related articles for article (PubMed ID: 29485359)
21. Halogenated trimethoprim derivatives as multidrug-resistant Staphylococcus aureus therapeutics.
Nilchan N; Phetsang W; Nowwarat T; Chaturongakul S; Jiarpinitnun C
Bioorg Med Chem; 2018 Oct; 26(19):5343-5348. PubMed ID: 29784273
[TBL] [Abstract][Full Text] [Related]
22. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
Adra M; Lawrence KR
Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
[TBL] [Abstract][Full Text] [Related]
23. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity on Staphylococcus aureus of original trimethoprim analogues tested alone or in association with sulfamethoxazole.
Kassis J; Simeon De Buochberg M; Giral L; Calas M; Maillols H; Despaux E; Attisso MA
J Chemother; 1989 Jul; 1(4 Suppl):214-7. PubMed ID: 16312375
[No Abstract] [Full Text] [Related]
25. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
27. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
28. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Bismuth R; Jarlier V; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives.
Rashid U; Ahmad W; Hassan SF; Qureshi NA; Niaz B; Muhammad B; Imdad S; Sajid M
Bioorg Med Chem Lett; 2016 Dec; 26(23):5749-5753. PubMed ID: 28327306
[TBL] [Abstract][Full Text] [Related]
30. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
Kamme C; Melander A; Nilsson NI
Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
[TBL] [Abstract][Full Text] [Related]
31. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
[TBL] [Abstract][Full Text] [Related]
32. Deletion of
Li K; Li T; Yang SS; Wang XD; Gao LX; Wang RQ; Gu J; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223385
[TBL] [Abstract][Full Text] [Related]
33. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
[TBL] [Abstract][Full Text] [Related]
34. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination.
Marks MI; Kazemi M; MacKay E
Antimicrob Agents Chemother; 1973 Nov; 4(5):555-9. PubMed ID: 4791490
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
Thorén A
Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
[TBL] [Abstract][Full Text] [Related]
36. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
Hahn H; Kirov A
Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
[TBL] [Abstract][Full Text] [Related]
37. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole.
Minato Y; Dawadi S; Kordus SL; Sivanandam A; Aldrich CC; Baughn AD
Nat Commun; 2018 Mar; 9(1):1003. PubMed ID: 29520101
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing.
Cox KK; Alexander B; Livorsi DJ; Heintz BH
J Infect; 2017 Dec; 75(6):486-492. PubMed ID: 28919346
[TBL] [Abstract][Full Text] [Related]
40. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
